Question 1

What areas does EVALAR JSC focus on within the pharmaceuticals industry?

Accepted Answer

EVALAR JSC is a  in the Pharmaceuticals industry. It researches, develops, and delivers medicinal products — covering prescription drugs, OTC medicines, biologics, and specialty therapeutics. The company serves healthcare providers, hospital networks, retail pharmacies, and regulated distribution channels.

Question 2

How long has EVALAR JSC been active in the industry?

Accepted Answer

EVALAR JSC has been operating since 1991. That experience reflects well-established R&D capabilities, deeper regulatory knowledge, and long-standing relationships with clinical partners and approved suppliers.

Question 3

Where does EVALAR JSC operate from?

Accepted Answer

EVALAR JSC is headquartered in Sotsialisticheskaya st. 23/6. Operating location determines regulatory jurisdiction — US-based companies follow FDA frameworks, while others operate under EMA, WHO, or local health authority requirements.

Question 4

How does EVALAR JSC function within the pharmaceuticals sector?

Accepted Answer

EVALAR JSC operates as a . Innovator companies develop and patent new drug compounds; generic manufacturers produce off-patent formulations; distributors supply products to pharmacy, hospital, and clinical channels. EVALAR JSC may operate across more than one of these roles.

Question 5

Where can I access EVALAR JSC's full profile on Nexus Platform?

Accepted Answer

Visit nexusplatform.ai/company/details/evalar.com for the complete profile — company type, key contacts, product range, therapeutic areas, and certifications, all in one place.

Question 6

Who is at the helm of EVALAR JSC?

Accepted Answer

EVALAR JSC is led by Natalia Rodionova, Ведущий Менеджер По Работе С Аптечными Сетями. Leadership in pharmaceuticals typically comes from clinical research, regulatory affairs, medicinal chemistry, or commercial strategy — backgrounds that directly influence pipeline decisions and market positioning.

Question 7

What does Natalia Rodionova oversee at EVALAR JSC?

Accepted Answer

Natalia Rodionova serves as Ведущий Менеджер По Работе С Аптечными Сетями at EVALAR JSC, responsible for drug development pipelines, regulatory submissions, quality assurance, and commercial growth across prescription and OTC channels.

Question 8

How do I get in touch with EVALAR JSC's team?

Accepted Answer

Key contacts are listed directly on the Nexus Platform profile at nexusplatform.ai/company/details/evalar.com.

Question 9

What does EVALAR JSC's product portfolio include?

Accepted Answer

EVALAR JSC offers various products as part of its pharmaceuticals range — spanning solid oral forms (tablets, capsules), injectables, biologics, topical treatments, and OTC medicines across multiple therapeutic categories.

Question 10

Which therapeutic areas do EVALAR JSC's products cover?

Accepted Answer

EVALAR JSC's products, including various products, target {{therapeuticArea}}. Therapeutic focus varies across companies — ranging from oncology, cardiovascular, and CNS to infectious disease, metabolic disorders, and dermatology — each with distinct regulatory and clinical requirements.

Question 11

Can EVALAR JSC's products be sourced through B2B or wholesale channels?

Accepted Answer

If EVALAR JSC operates as a manufacturer or distributor, bulk supply and wholesale options are likely available. Reach their commercial team at nexusplatform.ai/company/details/evalar.com.

Question 12

What active and inactive ingredients does EVALAR JSC work with?

Accepted Answer

EVALAR JSC uses various inputs across its pharmaceutical formulations. Key inputs include active pharmaceutical ingredients (APIs), excipients (binders, coatings, fillers), and biologics-derived compounds — all sourced and qualified to pharmacopeial standards such as USP, BP, or EP.

Question 13

What measures does EVALAR JSC take to guarantee ingredient integrity?

Accepted Answer

EVALAR JSC qualifies various inputs through approved vendor audits, certificate of analysis verification, pharmacopeial testing, and compliance with FDA 21 CFR, ICH guidelines, and cGMP standards — ensuring full traceability from raw material to finished dose.

Question 14

Which certifications does EVALAR JSC currently hold?

Accepted Answer

EVALAR JSC holds relevant certifications — issued by authorities such as the FDA, EMA, WHO, ISO, or ICH. These credentials confirm that the company's facilities, processes, and products meet the regulatory standards required for market authorization and distribution.

Question 15

What weight do EVALAR JSC's certifications carry with healthcare buyers and partners?

Accepted Answer

Certifications signal to healthcare buyers and distribution partners that EVALAR JSC's products meet independently verified standards. FDA approval, cGMP compliance, and ISO certification reduce procurement risk, satisfy formulary requirements, and are often a prerequisite for entry into hospital, clinical, and retail pharmacy channels.

EVALAR JSC Decision Maker Intelligence

Decision Maker Coverage

Natalia Rodionova

Dmitry Palchak

Pavel Konovalov

Related Companies

24 people records

Business overview

EVALAR JSC Operating Signals

Reach people and teams at EVALAR JSC

People and Company Questions

Fuel growth with unified, Trusted Data

Prospecting

Enrichment

Discovery & Demo

My Trade Guru